The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand

Por Yang, Nai-Ying, Lopez-Bergami, Pablo, Goydos, James S., Yip, Dana, Walker, Ameae M., Pasquale, Elena B., Ethell, Iryna
Publicado em 2010

Re-wired ERK-JNK signaling pathways in melanoma

Por Lopez-Bergami, Pablo, Huang, Conway, Goydos, James S., Yip, Dana, Bar-Eli, Menashe, Herlyn, Meenhard, Smalley, Keiran S. M., Mahale, Alka, Eroshkin, Alexey, Aaronson, Stuart, Ronai, Ze’ev
Publicado em 2007

A Phase 0 Trial of Riluzole in Patients with Resectable Stage III and IV Melanoma

Por Yip, Dana, Le, Maithao N., Chan, Joseph L.-K., Lee, Jonathan H., Mehnert, Janice A., Yudd, Anthony, Kempf, Jeffery, Shih, Weichung J., Chen, Suzie, Goydos, James S.
Publicado em 2009

Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinom...

Por Yip, Dana T., Hassan, Maria, Pazaitou-Panayiotou, Kalliopi, Ruan, Daniel T., Gawande, Atul A., Gaz, Randall D., Moore, Francis D., Hodin, Richard A., Stephen, Antonia E., Sadow, Peter M., Daniels, Gilbert H., Randolph, Gregory W., Parangi, Sareh, Lubitz, Carrie C.
Publicado em 2011

MDM4 is a key therapeutic target in cutaneous melanoma

Por Gembarska, Agnieszka, Luciani, Flavie, Fedele, Clare, Russell, Elisabeth A, Dewaele, Michael, Villar, Stéphanie, Zwolinska, Aleksandra, Haupt, Sue, de Lange, Job, Yip, Dana, Goydos, James, Haigh, Jody J, Haupt, Ygal, Larue, Lionel, Jochemsen, Aart, Shi, Hubing, Moriceau, Gatien, Lo, Roger S, Ghanem, Ghanem, Shackleton, Mark, Bernal, Federico, Marine, Jean-Christophe
Publicado em 2012